Skip to content
drillr.ai
Sign up

RGC

Regencell Bioscience Holdings Ltd.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · HK

$6.71
−2.19%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue—————
Cost of Revenue404.5K404.5K392.7K745.6K769.7K
Gross Profit(404.5K)(404.5K)(392.7K)(745.6K)(769.7K)
Operating Expenses
R&D Expense2.2M1.3M948.3K1.1M1.6M
SG&A Expense12.8M10.0M2.4M2.9M4.7M
General & Admin Expense2.8M—2.4M2.8M4.4M
Selling & Marketing Expense4.3K—8.0K125.4K262.7K
Other Expenses—————
Total Operating Expenses15.1M11.3M3.4M4.0M6.3M
Cost and Expenses15.5M11.7M3.8M4.7M6.3M
Operating Income (EBIT)(15.5M)(11.7M)(3.8M)(4.7M)(6.3M)
Non-Operating
Interest Income—————
Interest Expense—————
Net Interest Income—————
Other Non-Op Income/Expense208.3K22.5K185.8K373.5K211.3K
Non-Operating Income (excl Interest)(185.8K)—(185.8K)(373.5K)(211.3K)
EBT (Pre-Tax Income)(15.3M)(11.7M)(3.6M)(4.4M)(6.1M)
Income Tax Expense—————
Bottom Line
Net Income(15.3M)(11.7M)(3.6M)(4.3M)(5.9M)
Earnings from Cont. Ops(15.3M)(11.7M)(3.6M)(4.4M)(6.1M)
Earnings from Discont. Ops—————
Bottom Line Net Income(15.3M)(11.7M)(3.6M)(4.3M)(5.9M)
Per Share
Basic EPS($0.03)($0.02)($0.01)($0.01)($0.01)
Diluted EPS($0.03)($0.02)($0.01)($0.01)($0.01)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding494.7M494.6M494.5M494.5M494.5M
Diluted Shares Outstanding494.7M494.6M494.5M494.5M494.5M
Profitability Metrics
EBITDA(14.9M)(11.3M)(3.2M)(3.6M)(5.3M)
D&A456.3K404.5K392.7K745.6K769.7K
EBIT(15.3M)(11.7M)(3.6M)(4.4M)(6.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026